News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Gilead Sciences, Inc. Says U.S. Upholds One Viread Patent
May 21, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LOS ANGELES, May 20 (Reuters) - Gilead Sciences Inc said on Tuesday that U.S. patent officials have upheld one of the four challenged patents covering its AIDS medicine Viread.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Special edition
Deep Dive: Biopharma In Turmoil As Peter Marks Forced Out of FDA
May 9, 2025
·
2 min read
·
Annalee Armstrong
Manufacturing
Trump Orders FDA To Ease US Plant Expansion; Drops Hammer on Foreign Inspections
May 6, 2025
·
3 min read
·
Annalee Armstrong
Legal
States Sue RFK Jr., Makary, Seeking To Block HHS Cuts
May 6, 2025
·
2 min read
·
Tristan Manalac
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
May 2, 2025
·
6 min read
·
Heather McKenzie
